top of page

PATIENT SELECTION & ELIGIBILITY CRITERIA

Identify ten (10) patients that may benefit from 0.5 mg once daily Colchicine (MyinflaTM ER) and meet the DEMONSTRATE program eligibility criteria.

 

Data entry is de-identified and all management decisions are the discretion of the participating physician.

 

Eligibility Criteria:

  • Age > 18 years

  • Prior Myocardial Infarction

  • Not currently treated with Colchicine

  • No contraindications to Colchicine*

  • Ability to optimize patient's secondary prevention management within the next month (e.g. regularly scheduled appointment date or ability to schedule virtual / in person follow-up visit)

  • Unencumbered access to Colchicine (Myinfla ER):

    • Private insurance

    • Ability to cover out of pocket**

​

* Contraindications to Colchicine: strong P-glycoprotein (P-gp) inhibitors or strong CYP3A4 inhibitors, severe renal impairment (eGFR < 30 mL/min), severe hepatic impairment, existing blood dyscrasias.

​

** Myinfla’s current list price in Ontario is ≈ $0.50 per day

Copyright © Canadian Heart Research Centre 2022.  The content and materials on this website may not be reproduced or distributed without written authorization from the Canadian Heart Research Centre.

CHRC logo_H (3)_edited.png
bottom of page